Scinai Immunotherapeutics Ltd. financial data

Symbol
SCNI on Nasdaq
Location
Jerusalem, Israel
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 07 May 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,411,983,584 shares 84%
Common Stock, Shares, Outstanding 6,056,623,584 shares 81%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $989,000 USD -68%
Accounts Receivable, after Allowance for Credit Loss, Current $139,000 USD 17%
Assets, Current $1,506,000 USD -59%
Property, Plant and Equipment, Net $8,497,000 USD -17%
Operating Lease, Right-of-Use Asset $1,837,000 USD 81%
Assets $11,840,000 USD -20%
Employee-related Liabilities, Current $254,000 USD -35%
Accrued Liabilities, Current $527,000 USD 14%
Liabilities, Current $2,120,000 USD 27%
Operating Lease, Liability, Noncurrent $1,566,000 USD 145%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,740,000 USD 0%
Retained Earnings (Accumulated Deficit) $121,673,000 USD 4.1%
Stockholders' Equity Attributable to Parent $7,858,000 USD
Liabilities and Equity $11,840,000 USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 40,000,000,000 shares 100%
Common Stock, Shares, Issued 6,056,623,584 shares 81%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,131,000 USD -65%
Deferred Tax Assets, Valuation Allowance $23,699,000 USD -10%
Operating Lease, Liability $1,826,000 USD
Lessee, Operating Lease, Liability, to be Paid $3,113,000 USD
Property, Plant and Equipment, Gross $13,645,000 USD 121%
Operating Lease, Liability, Current $497,000 USD 37%
Lessee, Operating Lease, Liability, to be Paid, Year Two $384,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $426,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,287,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $384,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $23,377,000 USD -10%
Preferred Stock, Shares Issued 1,000 shares
Preferred Stock, Shares Authorized 1,000 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four $384,000 USD
Additional Paid in Capital $125,644,000 USD 3.6%
Preferred Stock, Shares Outstanding 1,000 shares
Deferred Tax Assets, Net of Valuation Allowance $23,415,000 USD -11%